UK markets closed

Biotest Aktiengesellschaft (0N6Z.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
43.60+0.10 (+0.23%)
At close: 4:45PM BST
Full screen
Previous close43.50
Open43.60
Bid0.00 x N/A
Ask0.00 x N/A
Day's range43.60 - 43.60
52-week range43.60 - 43.60
Volume114
Avg. volumeN/A
Market cap1.57B
Beta (5Y monthly)0.52
PE ratio (TTM)N/A
EPS (TTM)-0.84
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • EQS Group

    Biotest AG: Biotest identifies a benefit with trimodulin in a relevant subgroup of hospitalised COVID-19 patients

    DGAP-News: Biotest AG / Key word(s): Research Update11.10.2021 / 07:00 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest identifies a benefit with trimodulin in a relevant subgroup of hospitalised COVID-19 patients- Complete data set from the phase II ESsCOVID trial analysed- Post hoc subgroup analyses revealed a medical relevant benefit in hospitalised COVID-19 patients with early systemic inflammation- Biotest considers further clinical development of t

  • EQS Group

    Biotest AG: Takeover Offer: Grifols S.A. to make a voluntary public takeover offer for the shares of Biotest AG

    Biotest AG / Key word(s): OfferBiotest AG: Takeover Offer: Grifols S.A. to make a voluntary public takeover offer for the shares of Biotest AG17-Sep-2021 / 12:52 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.Ad-hoc RELEASEAnnouncement according to Article 17 European Market Abuse Regulation (MAR)Takeover Offer: Grifols S.A.

  • EQS Group

    Biotest AG: Biotest announces the new Renate & Hans Schleussner Award for scientific research

    DGAP-News: Biotest AG / Key word(s): Miscellaneous15.09.2021 / 07:00 The issuer is solely responsible for the content of this announcement.PRESS RELEASEBiotest announces the new Renate & Hans Schleussner Award for scientific research Award's aim is promotion of innovative research in the field of therapies with (hyper-) immunoglobulins In memory of the Schleussner family who founded Biotest, the new research award will be named the Renate & Hans Schleussner Award € 50,000 will be awarded for a p